Searchable abstracts of presentations at key conferences in endocrinology

ea0019p354 | Thyroid | SFEBES2009

Thyroxine induced cardiac failure in a young hypothyroid

King R , Mizban N , Smyllie JH , Rajeswaran C

Full replacement dose of thyroxine should not be administered initially to elderly hypothyroid patients, those with a history of coronary artery disease and to patients with long-standing severe hypothyroidism. Here, we present a 27-year-old lady with profound longstanding hypothyroidism, who developed cardiac failure on a small dose of thyroxine.She presented to her General Practitioner with longstanding symptoms of lethargy, poor concentration, constip...

ea0015p356 | Thyroid | SFEBES2008

The follow up of radioiodine treated hyperthyroid patients: the Bradford experience

Satish Kumar Sampath , King Rhodric , Wright Diane , Peacey Steve

There is a relative lack of data regarding the timing and in particular the severity of hypothyroidism post Radioiodine (RI). We retrospectively examined the timing and severity of hypothyroidism following RI in 213 patients, in relation to ‘target’ and actual follow up appointments, and the introduction of a nurse-led follow-up clinic. Hypothyroidism was defined as persistent elevation of TSH – mild (TSH 6.1–10 mU/l), moderate (TSH 10.1–50 mU/l) and s...

ea0011p114 | Clinical case reports | ECE2006

Biochemical screening for ret negative medullary thyroid carcinoma (MTC): a case report highlighting difficulties in the interpretation of pentagastrin stimulated calcitonin testing

Webb DR , Seevaratnam N , Suri M , King P

In cases of ret-oncogene positive Medullary Thyroid Carcinoma (MTC), national guidelines advocate screening of 1st degree relatives with the Pentagastrin Stimulation Test (PST) to identify those with C-cell hyperplasia, and therefore at risk of MTC. Prophylactic thyroidectomy is recommended in those with positive tests. We highlight the difficulties of quantifying risk in the relatives of a ret-negative patient.A 30 year-old man presented with a tender n...

ea0011p574 | Growth and development | ECE2006

Prolonged expression of the ACTH receptor, MC2-R, during 3T3-L1 adipocyte differentiation is dependent upon switching promoter usage to an adipocyte-specific, C/EBP-driven, downstream promoter

Noon LA , Clark AJL , O’Shaughnessy PJ , King PJ

The peptide hormone ACTH stimulates lipolysis and suppresses leptin production in adipocytes via the G-protein coupled seven transmembrane receptor, MC2-R. We have shown previously that PPARγ2 is the primary factor responsible for transactivation of the already identified murine MC2-R promoter in the differentiating 3T3-L1 adipocyte cell line. In this study we show that despite the activity of this promoter being transient during differentiation, MC2-R mRNA remains elevat...

ea0007p203 | Steroids | BES2004

Dehydroepiandrosterone sulphate (DHEAS) inhibits growth of human vascular endothelial cells

Hinson J , Renshaw D , Vakharia K , King P

Dehydroepiandrosterone sulphate is a steroid product of the adrenal gland, which circulates in micromolar concentrations, but whose function is unclear. Epidemiological studies have suggested that high circulating DHEAS levels may be protective against cardiovascular disease. The present study was designed to determine whether DHEAS altered vascular cell growth using the human microvascular endothelial cell line HMEC.HMECs were grown in MCDB131 medium co...

ea0004oc15 | Endocrine tumours and neoplasia | SFE2002

Effect of insulin-like growth factor binding protein-3 (IGFBP-3) on colon cancer epithelial cells growth and apoptosis

Saksena M , Miraki-Moud F , King P , Camacho-Hubner C

The insulin-like growth factors together with the IGF receptors, IGFBPs and IGFBP proteases are involved in the regulation of somatic growth and cellular proliferation in vivo and in vitro. Our previous studies demonstrated that overexpression of IGFBP-2 in colon cancer cells (Caco-2) was associated with increased cell proliferation and tumorigenesis. The wild-type Caco-2 cells express and secrete IGFBP-2, IGFBP-4, IGF1R and growth hormone receptors but not IGFBP-3. Therefore,...

ea0050oc3.2 | Obesity, Diabetes Thyroid | SFEBES2017

Hypothyroidism is a risk factor for acquiring diabetes in women with Turner Syndrome

Cameron-Pimblett Antoinette , King Thomas F.J. , La Rosa Clementina , Conway Gerard S.

Introduction: The adult Turner Syndrome (TS) clinic at UCLH has collected data on over 800 women, attending for up to 20 years comprising over 8000 clinic visits. Data from this cohort forms the Turner Life Course Project. This large dataset allows analysis of pathogenesis of common chronic conditions including diabetes mellitus (DM) and hypothyroidism. There is some debate about the classification of DM associated with TS, with an over representation of up to 11-fold of type ...

ea0050oc3.2 | Obesity, Diabetes Thyroid | SFEBES2017

Hypothyroidism is a risk factor for acquiring diabetes in women with Turner Syndrome

Cameron-Pimblett Antoinette , King Thomas F.J. , La Rosa Clementina , Conway Gerard S.

Introduction: The adult Turner Syndrome (TS) clinic at UCLH has collected data on over 800 women, attending for up to 20 years comprising over 8000 clinic visits. Data from this cohort forms the Turner Life Course Project. This large dataset allows analysis of pathogenesis of common chronic conditions including diabetes mellitus (DM) and hypothyroidism. There is some debate about the classification of DM associated with TS, with an over representation of up to 11-fold of type ...

ea0044p194 | Obesity and Metabolism | SFEBES2016

Impact of weight gain on long term outcomes in women with turner syndrome: The turner syndrome life course project

Pimblett Antoinette , King Thomas J , Talaulikar Vikram , Davies Melanie , Conway Gerard

Turner syndrome (TS) affects over 15,000 females in the UK and is defined by the loss of X chromosome material. In the setting of an adult clinic we can observe adverse outcomes and determine their risk factors. For instance women with TS have an excess risk of hypertension, diabetes, fatty liver and osteoporosis. The Turner Syndrome Life Course Project at UCLH has collected data from over 750 women with TS over 20 years. Here we report the influence of weight on these outcome...

ea0041ep32 | Adrenal cortex (to include Cushing's) | ECE2016

Adrenal pigmentation in PPNAD is a result of melanin deposition and associated with upregulation of the melanocortin 1 receptor

Cavlan Dominic , Evagora Chris , Berney Dan , Storr Helen , Drake Will , King Peter

Primary pigmented nodular adrenal disease (PPNAD) is a form of bilateral adrenocortical hyperplasia characterised by small to normal sized adrenal glands containing multiple small cortical pigmented nodules. It may occur independently, but 90% of cases are a manifestation of the Carney complex. Most cases of PPNAD are diagnosed before age 30, and are the result of a germline mutation in PRKAR1A or PDE11A, leading to upregulation of cAMP signalling. It is a cause of ACTH-indepe...